CN110326788A - 一种苦荞d-手性肌醇复合降糖压片及其制备方法 - Google Patents
一种苦荞d-手性肌醇复合降糖压片及其制备方法 Download PDFInfo
- Publication number
- CN110326788A CN110326788A CN201910761225.1A CN201910761225A CN110326788A CN 110326788 A CN110326788 A CN 110326788A CN 201910761225 A CN201910761225 A CN 201910761225A CN 110326788 A CN110326788 A CN 110326788A
- Authority
- CN
- China
- Prior art keywords
- concentrate
- chiro
- bitter buckwheat
- inositol
- soybean
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 title claims abstract description 60
- 235000009419 Fagopyrum esculentum Nutrition 0.000 title claims abstract description 50
- 230000002218 hypoglycaemic effect Effects 0.000 title claims abstract description 33
- -1 d-chiro-inositol compound Chemical class 0.000 title claims abstract description 22
- 241000219051 Fagopyrum Species 0.000 title claims description 48
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 235000008504 concentrate Nutrition 0.000 claims abstract description 84
- 239000012141 concentrate Substances 0.000 claims abstract description 84
- 239000000470 constituent Substances 0.000 claims abstract description 67
- 244000068988 Glycine max Species 0.000 claims abstract description 45
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 45
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 44
- 235000009854 Cucurbita moschata Nutrition 0.000 claims abstract description 42
- MGXWVYUBJRZYPE-YUGYIWNOSA-N incretin Chemical class C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=C(O)C=C1 MGXWVYUBJRZYPE-YUGYIWNOSA-N 0.000 claims abstract description 41
- 239000000859 incretin Substances 0.000 claims abstract description 41
- CDAISMWEOUEBRE-LKPKBOIGSA-N 1D-chiro-inositol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O CDAISMWEOUEBRE-LKPKBOIGSA-N 0.000 claims abstract description 38
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 36
- 235000009852 Cucurbita pepo Nutrition 0.000 claims abstract description 31
- 235000020354 squash Nutrition 0.000 claims abstract description 31
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 26
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 25
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 25
- 239000000022 bacteriostatic agent Substances 0.000 claims abstract description 25
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 22
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 21
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 21
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 21
- 241000218231 Moraceae Species 0.000 claims abstract description 21
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 21
- 239000009636 Huang Qi Substances 0.000 claims abstract description 20
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 19
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 19
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 19
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 19
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000000811 xylitol Substances 0.000 claims abstract description 19
- 235000010447 xylitol Nutrition 0.000 claims abstract description 19
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 19
- 229960002675 xylitol Drugs 0.000 claims abstract description 19
- 240000004244 Cucurbita moschata Species 0.000 claims abstract description 18
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims abstract description 13
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 13
- WHGYBXFWUBPSRW-UHFFFAOYSA-N Cycloheptaamylose Natural products O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO WHGYBXFWUBPSRW-UHFFFAOYSA-N 0.000 claims abstract description 12
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 11
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 11
- 239000000845 maltitol Substances 0.000 claims abstract description 8
- 235000010449 maltitol Nutrition 0.000 claims abstract description 8
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims abstract description 8
- 229940035436 maltitol Drugs 0.000 claims abstract description 8
- 244000234609 Portulaca oleracea Species 0.000 claims abstract 8
- 244000302512 Momordica charantia Species 0.000 claims abstract 5
- 238000000034 method Methods 0.000 claims description 63
- 238000000605 extraction Methods 0.000 claims description 38
- 150000004676 glycans Chemical class 0.000 claims description 34
- 229920001282 polysaccharide Polymers 0.000 claims description 34
- 239000005017 polysaccharide Substances 0.000 claims description 34
- 102000004190 Enzymes Human genes 0.000 claims description 20
- 108090000790 Enzymes Proteins 0.000 claims description 20
- 230000007062 hydrolysis Effects 0.000 claims description 12
- 238000006460 hydrolysis reaction Methods 0.000 claims description 12
- 230000002195 synergetic effect Effects 0.000 claims description 11
- 230000002255 enzymatic effect Effects 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 7
- 239000002131 composite material Substances 0.000 claims 7
- 240000001592 Amaranthus caudatus Species 0.000 claims 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims 1
- 235000011613 Pinus brutia Nutrition 0.000 claims 1
- 241000018646 Pinus brutia Species 0.000 claims 1
- 235000012735 amaranth Nutrition 0.000 claims 1
- 239000004178 amaranth Substances 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 1
- 239000010931 gold Substances 0.000 claims 1
- 229910052737 gold Inorganic materials 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 239000000284 extract Substances 0.000 abstract description 61
- 239000002994 raw material Substances 0.000 abstract description 23
- 241000196324 Embryophyta Species 0.000 abstract description 8
- 244000130270 Fagopyrum tataricum Species 0.000 abstract description 2
- 235000014693 Fagopyrum tataricum Nutrition 0.000 abstract description 2
- 240000008620 Fagopyrum esculentum Species 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 107
- 239000007788 liquid Substances 0.000 description 69
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 63
- 235000019441 ethanol Nutrition 0.000 description 57
- 238000002604 ultrasonography Methods 0.000 description 46
- 239000002904 solvent Substances 0.000 description 40
- 238000009777 vacuum freeze-drying Methods 0.000 description 34
- 240000001980 Cucurbita pepo Species 0.000 description 24
- 229940088598 enzyme Drugs 0.000 description 24
- 239000000243 solution Substances 0.000 description 24
- 206010012601 diabetes mellitus Diseases 0.000 description 19
- 238000001035 drying Methods 0.000 description 18
- 240000001910 Momordica cochinchinensis Species 0.000 description 16
- 230000000694 effects Effects 0.000 description 16
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 15
- 241000219304 Portulacaceae Species 0.000 description 14
- 108010073771 Soybean Proteins Proteins 0.000 description 13
- 235000019710 soybean protein Nutrition 0.000 description 13
- 239000003513 alkali Substances 0.000 description 12
- 239000008367 deionised water Substances 0.000 description 12
- 229910021641 deionized water Inorganic materials 0.000 description 12
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 239000006228 supernatant Substances 0.000 description 12
- 235000000832 Ayote Nutrition 0.000 description 11
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 11
- 241000233866 Fungi Species 0.000 description 11
- 239000004365 Protease Substances 0.000 description 11
- 235000015136 pumpkin Nutrition 0.000 description 11
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 11
- 239000002253 acid Substances 0.000 description 10
- 239000007853 buffer solution Substances 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 238000001556 precipitation Methods 0.000 description 10
- 239000001509 sodium citrate Substances 0.000 description 10
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 10
- 235000013305 food Nutrition 0.000 description 9
- 101100042793 Gallus gallus SMC2 gene Proteins 0.000 description 8
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 244000046052 Phaseolus vulgaris Species 0.000 description 7
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 7
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 6
- CAXNYFPECZCGFK-UHFFFAOYSA-N 2-phenyl-2-pyridin-2-ylacetonitrile Chemical compound C=1C=CC=NC=1C(C#N)C1=CC=CC=C1 CAXNYFPECZCGFK-UHFFFAOYSA-N 0.000 description 6
- 241000238631 Hexapoda Species 0.000 description 6
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 108091005804 Peptidases Proteins 0.000 description 6
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 6
- 235000019764 Soybean Meal Nutrition 0.000 description 6
- 241000607479 Yersinia pestis Species 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 230000009849 deactivation Effects 0.000 description 6
- 238000005238 degreasing Methods 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000010410 dusting Methods 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 239000003208 petroleum Substances 0.000 description 6
- 230000001376 precipitating effect Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 235000019419 proteases Nutrition 0.000 description 6
- 238000010298 pulverizing process Methods 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 239000004455 soybean meal Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 238000009210 therapy by ultrasound Methods 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- 108010059892 Cellulase Proteins 0.000 description 5
- 108090000526 Papain Proteins 0.000 description 5
- 108010089934 carbohydrase Proteins 0.000 description 5
- 229940106157 cellulase Drugs 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 229940055729 papain Drugs 0.000 description 5
- 235000019834 papain Nutrition 0.000 description 5
- 238000009736 wetting Methods 0.000 description 5
- 206010022489 Insulin Resistance Diseases 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 239000010282 Emodin Substances 0.000 description 3
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 108010028144 alpha-Glucosidases Proteins 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000001151 other effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 240000006079 Schisandra chinensis Species 0.000 description 2
- 235000008422 Schisandra chinensis Nutrition 0.000 description 2
- 238000009098 adjuvant therapy Methods 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 231100001028 renal lesion Toxicity 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- FYGDTMLNYKFZSV-WFYNLLPOSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,3s,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-WFYNLLPOSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 102100036009 5'-AMP-activated protein kinase catalytic subunit alpha-2 Human genes 0.000 description 1
- 102000011690 Adiponectin Human genes 0.000 description 1
- 108010076365 Adiponectin Proteins 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 102400000748 Beta-endorphin Human genes 0.000 description 1
- 101800005049 Beta-endorphin Proteins 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 229920000018 Callose Polymers 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 208000032781 Diabetic cardiomyopathy Diseases 0.000 description 1
- 108010001394 Disaccharidases Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 101000783681 Homo sapiens 5'-AMP-activated protein kinase catalytic subunit alpha-2 Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 244000228367 Lewisia rediviva Species 0.000 description 1
- 235000007279 Lewisia rediviva Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000235526 Mucor racemosus Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 108091006300 SLC2A4 Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 241000294142 Vascellum Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 239000001202 beta-cyclodextrine Substances 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- WOPZMFQRCBYPJU-NTXHZHDSSA-N beta-endorphin Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C1=CC=CC=C1 WOPZMFQRCBYPJU-NTXHZHDSSA-N 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 208000004104 gestational diabetes Diseases 0.000 description 1
- 230000024924 glomerular filtration Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003446 memory effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000004923 pancreatic tissue Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 229940064064 purslane extract Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种苦荞D‑手性肌醇复合降糖压片及其制备方法。所述片剂由以下原辅料制备而成:苦荞D‑手性肌醇浓缩液15~30%、苦瓜浓缩液3~5%、桑葚浓缩液3~5%、决明子浓缩液3~7%、西洋参浓缩液3~7%、橘皮浓缩液3~7%、金银花浓缩液3~5%、葛根浓缩液4~8%、黄芪浓缩液4~8%、马齿苋抑菌剂7~14%、南瓜多糖6~10%、黑木耳多糖6~13%、大豆降糖肽7~16%、木糖醇3~20%、麦芽糖醇3~10%、柠檬酸0.3~0.8%、β‑环状糊精3.4~8.7%、硬脂酸镁0.5~1%。本发明的特点是以高含量D‑手性肌醇的苦荞提取物为原料,制得一种具有降糖效果的复合片剂。本产品是以天然植物降糖活性成分作为原辅料,并以马齿苋活性成分作为天然抑菌剂,安全可靠,可放心食用。
Description
技术领域
本发明涉及保健食品技术领域,是以苦荞D-手性肌醇为原料制备的一种具有降糖效果的片剂。
背景技术
糖尿病因其发病机制不同可分为I型糖尿病、II型糖尿病、妊娠糖尿病和其他类型糖尿病,其中II型糖尿病患者约占90%,这类患者备受关注。但是,目前对糖尿病的治疗仅限于症状的缓解阶段,很难达到治愈的水平,且有关降糖药物副作用较大,长期服用对肝脏和脾胃均有一定损伤。研制功效佳、副作用小的降糖药物用于糖尿病的治疗成为现阶段人类亟待解决的世界性难题。相关研究发现,天然植物所含的黄酮类化合物、多糖、生物碱、肌醇等活性成分均有良好的降糖效果,且几乎无副作用,开发相关食品为预防和辅助治疗相关疾病提供了可行思路。
发明内容
以苦荞D-手性肌醇为主要原料开发适合糖尿病人食用的片剂,既能满足对口感的需求,又不会使血糖升高,并能达到预防和辅助治疗糖尿病及相关代谢疾病的目的。本发明提供了一种配比科学、安全健康、适于糖尿病患者服用的苦荞D-手性肌醇复合降糖压片的制备方法。
本发明的目的是通过以下技术方案实现的:
一种苦荞D-手性肌醇复合降糖压片,由下列质量分数的原辅料制成:
一种苦荞D-手性肌醇复合降糖压片,按照质量百分比由苦荞D-手性肌醇浓缩液15~30%、苦瓜浓缩液3~5%、桑葚浓缩液3~5%、决明子浓缩液3~7%、西洋参浓缩液3~7%、橘皮浓缩液3~7%、金银花浓缩液3~5%、葛根浓缩液4~8%、黄芪浓缩液4~8%、马齿苋抑菌剂7~14%、南瓜多糖6~10%、黑木耳多糖6~13%、大豆降糖肽7~16%、木糖醇3~20%、麦芽糖醇3~10%、柠檬酸0.3~0.8%、β-环状糊精3.4~8.7%、硬脂酸镁0.5~1%共100%。
一种苦荞D-手性肌醇复合降糖压片的制备,其步骤如下:
一、称取一定量的原辅料,分别进行如下操作:原料→预处理→提取→浓缩→真空干燥→粉碎,具体要求如下:
(1)原料选取:选取新鲜无虫害原料备用;
(2)预处理:将各原辅料40℃恒温干燥箱烘干,超微粉碎,过80目筛;
(3)苦荞D-手性肌醇提取:采用三维立体超声波提取技术对苦荞D-手性肌醇进行提取,经单因素及正交试验探究出最佳提取条件为:50%乙醇提取,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
(4)苦瓜活性成分提取:采用三维立体超声波提取技术对苦瓜活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
(5)桑葚活性成分提取:采用三维立体超声波提取技术对桑葚活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
(6)决明子活性成分提取:采用三维立体超声波提取技术对决明子活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
(7)西洋参活性成分提取:采用三维立体超声波提取技术对西洋参活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
(8)橘皮活性成分提取:采用三维立体超声波提取技术对橘皮活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
(9)金银花活性成分提取:采用三维立体超声波提取技术对金银花活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
(10)葛根活性成分提取:采用三维立体超声波提取技术对葛根活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
(11)黄芪活性成分提取:采用三维立体超声波提取技术对黄芪活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
(12)马齿苋抑菌剂提取:采用三维立体超声辅助提取技术,以蒸馏水为提取溶剂,料液比为1:30~50,温度为50 ℃,功率400 W,时间为30 min,浓缩至含水量低于15%;
(13)南瓜多糖提取:采用超声波协同纤维素酶法提取南瓜多糖,柠檬酸钠缓冲液调节pH在4.0~5.5,温度在45~65℃之间(不同来源的纤维素酶有不同的最佳作用条件)加酶质量分数1.5%,超声功率200 W,超声时间20min,采用Sevage法脱蛋白得南瓜精多糖溶液,经过浓缩、醇沉、真空冻干得到南瓜精多糖,多糖质量分数高达70%。
(14)黑木耳多糖:采用超声波协同复合酶法提取黑木耳多糖,柠檬酸钠缓冲液调节pH在4.0~5.5,木瓜蛋白酶、糖化酶、果胶酶(1:1:1),加酶量700 U/g(原料),料液比1:60、酶解pH 5、酶解时间1.5 h、酶解温度50 ℃,超声功率200 W,超声时间20min,采用Sevage法脱蛋白得黑木耳精多糖溶液,经过浓缩、醇沉、真空冻干得到黑木耳精多糖。
(15)大豆降糖肽提取:
1)碱提酸沉提大豆蛋白:大豆豆粕用石油醚(1:15~20)脱脂,烘干。将脱脂大豆豆粕用去离子水溶解,料液比1:10,用0.2 mol/L Na OH溶液调节pH至8.5~9.0,静置60 min,5000r/min离心15 min,上清液用0.2 mol/L HCl溶液调p H至4.0~4.5,静置30 min,再次离心,沉淀即为大豆蛋白。
2)超声前处理-酶解大豆降糖肽:将大豆蛋白粉按料液比1:20~25加入去离子水,超声时间30min、超声处理温度50℃、超声功率400W。之后调节pH至 9~11,加碱性蛋白酶1.5~2.5% ,酶解温度50~60℃,酶解时间4~6 h,升温至70℃灭酶,调节p H,离心,上清液浓缩,真空冻干得到大豆降糖肽。
(16)真空冻干:用真空冻干机在0.4~0.7mbar,温度为-50℃~ -40℃。
(17)粉碎:将真空冻干的南瓜多糖、黑木耳多糖和大豆降糖肽粉碎成40目~80目的固体粉末,即得冻干粉。
二、三维混合:将南瓜多糖、黑木耳多糖、大豆降糖肽、木糖醇和一些其他辅料放入三维混合机搅拌30min~60min;
三、制粒:将混合后原辅料灭菌,加入适量上述提取液浓缩液,敷粉,粉碎,加入适量乙醇润湿后制粒;
四、压片:经60℃干燥后,加入硬脂酸镁,放入压片机中直接压片,制得直径为(0.3cm~1.0cm),厚度为(0.3cm~0.4cm)的复合片剂。
本发明选择苦荞为原料,提取降糖成分D-手性肌醇,再加以一些其他天然植物降糖活性成分进行复配,这些原辅料能起到预防和治疗糖尿病及一些相关代谢疾病的作用,具体功效如下:
1、苦荞D-手性肌醇:D-手性肌醇(DCI)是一种胰岛素促敏剂,它通过改善胰岛素的功能发挥降糖功效。正常人血液和尿液中都含有一定浓度的DCI,而在Ⅱ型糖尿病患者的血液中几乎检测不到DCI,但在尿液中的含量则高于正常人数倍。因此这些患者可能由于代谢紊乱,导致DCI流失太快,最终造成胰岛作用的信号传递受阻。有研究发现,口服DCI可以补充Ⅱ型糖尿病患者DCI的流失,缓解糖尿病病症。苦荞是DCI含量较丰富的植物之一,麸皮中含量高达20%。
2、南瓜多糖:南瓜多糖是一种天然水溶性植物多糖,具有显著的降血糖功效。含有的单糖主要有葡萄糖、半乳糖、鼠李糖、阿拉伯糖。 南瓜多糖对糖尿病大鼠肾脏有改善作用,对早期糖尿病肾脏病变有保护作用。主要表现在南瓜多糖能使糖尿病大鼠尿微中量白蛋白浓度及血糖下降,改善肾小球滤过屏障通透性;肾肥大指数及肾皮质Na+、K+-ATP酶活性恢复至接近正常水平,减少了糖尿病肾脏病变。
3、苦瓜:苦瓜作为一种药食两用植物,含有皂苷、多糖、蛋白和黄酮等多种生物活性成分,具有良好的保健功能,其中降血糖作用是苦瓜最重要的功能之一。降糖机理主要有:(1) 苦瓜能够修复受损的β-细胞,增加胰岛素水平,增强胰岛素的敏感性;(2)通过抑制α-葡萄糖苷酶和α-淀粉酶的活性减少葡萄糖的肠道吸收;(3)通过刺激甲状腺素和脂联素的合成与释放增强AMPK的活性。
4、桑葚:桑葚含有多种维生素、有机酸、蛋白质、游离氨基酸、微量元素等营养成分和桑葚多糖、白藜芦醇、花青素等活性成分,具有降血脂、降血糖、护肝、防癌、防心血管疾病、抗突变、抗诱变、抗衰老、抗病毒及调节免疫等多种生理功效,是药食两用的食品。主要的降糖成分有氨基酸和生物碱:(1)桑葚中的精氨酸可促进胰岛素生成和分泌;(2)生物碱1-脱氧野尻霉素,能同小肠中的麦芽糖酶、蔗糖酶和乳糖酶等二糖酶结合,从而阻碍了体内的二糖与α-糖苷酶的结合,能够显著控制饭后血糖的上升。
5、决明子:决明子属于豆科植物,具有降血脂、降血压、降血糖、润肠通便、保肝、明目、抗氧化、抗衰老、抑菌及抗癌等作用,是一种药食两用的药材。
决明子治疗糖尿病的主要活性成分有大黄素和大黄酸,大黄酸在改善糖尿病小鼠体重、饮食饮水量及糖尿病小鼠的氧化应激等方面优于大黄素;大黄酸和大黄素对线粒体中ROS的产生均有很强的抑制作用,因此对糖尿病造成的氧化应激有良好的治疗作用。
6、西洋参:西洋参可以降低胰岛素抵抗大鼠总胆固醇、甘油三酯和游离脂肪酸水平,起作用的主要有西洋参总皂苷和西洋参多糖。此外,西洋参还有显著的提高机体免疫力、降血压、抗缺氧、抗疲劳、抗癌、保护肝功能、增强记忆力等功效。
7、橘皮:精油、果胶、色素等是橘皮的主要功能性成分,具有抗菌消炎、抗衰老、抗氧化、抗肿瘤、降血压等多种功能。橘皮精油是淡黄色透明液体 (含有橘黄色素),有愉悦的橘香味,是一类天然绿色香料;果胶是多糖类高分子,可以作食品的增稠剂,稳定剂,乳化剂等,并有降血糖,血脂,减少胆固醇,疏通血管等功效;橘皮含有一类安全可靠、性能较稳定的天然色素,以脂溶性色素类胡萝卜素为主,有很强的着色能力。橘皮提取物可作为天然增香剂、天然色素。天然稳定剂添加到食品中。
8、马齿苋:马齿苋有很强的抑菌功效,尤其是对许多细菌,如大肠杆菌,沙门氏菌、变形杆菌、志贺氏菌、金黄色葡萄球菌、枯草芽抱杆菌、蜡样芽抱杆菌等抑菌作用较强,而对霉状杆菌抑制作用不明显;对一些霉菌也有抑制作用,如总状毛霉、赤霉、交链抱霉、黄曲霉等抑制作用也较强。因此,马齿苋提取液是良好的抑菌剂,可作为天然植物抑菌剂添加到食品中。
9、黑木耳多糖:黑木耳多糖为黑木耳子实体的主要功能性成分,主要由水溶性β-D-葡聚糖、水不溶性β-D-葡聚糖和两种酸性杂多糖构成。具有降血糖、降血脂、抗炎、抗凝血、抗肿瘤、抗衰老、抗血栓形成、降低血液粘度等作用。
10、金银花:金银花的活性成分种类丰富,主要包含挥发油、黄酮类、有机酸及多糖等,具有抗氧化、降血糖、调节免疫等功效,广泛应用于医药、保健食品和日用品等的研发。
11、葛根-黄芪:葛根是药食同源食品,黄芪是可用于保健食品的中草药。不少研究表明,葛根和黄芪配伍对治疗Ⅱ型糖尿病胰岛素抵抗和糖尿病肾病、糖尿病心肌病等有帮助。黄芪多糖能部分回复胰岛素抵抗大鼠受损的胰岛素信号转导,改善胰岛素抵抗;葛根素促进胰岛素分泌,促进脑垂体和胰腺组织β-内啡肽的合成,上调脂肪、骨骼肌GLUT4基因表达,促进机体摄取利用葡萄糖。
12、五味子:五味子味甘酸性温,甘能益脾,酸能收敛,敛之极则藏,肾主藏,故为补肾之要药、治疗糖尿病之上品。五味子多糖是主要的活性成分,对四氧嘧啶、STZ等诱导的小鼠高血糖具有显著降糖作用,并且对酒精、四氯化碳、高脂饮食等诱导的肝损伤有良好的防治作用。
13、大豆降糖肽: 大豆蛋白酶解产物含多种生物活性肽,如抗氧化肽、降糖肽、降血压肽等。其中降糖肽的主要作用机理是:豆粕蛋白酶解产物具有优异的α-葡萄糖苷酶抑制活性,在体内能够竞争性抑制小肠葡萄糖苷酶活性,延缓或抑制葡萄糖的吸收,因此能够有效降低餐后血糖,可用于辅助治疗Ⅱ型糖尿病。
本发明的特点:
(1)以含高D-手性肌醇的苦荞提取物为原料,制得糖尿病患者可食用,也可预防或辅助治疗Ⅱ型糖尿病的保健食品。
(2)本发明产品以马齿苋活性成分作为天然抑菌剂,不添加其他抑菌剂和防腐剂,健康安全,可放心食用。
具体实施方式
下面对本发明的技术方案作进一步的说明,但并不局限于此,凡是对本发明技术方案进行修改或者同等替换,而不脱离本发明技术的精神和范围,均应涵盖在本发明的保护范围中。
实施例1
一种苦荞D-手性肌醇复合降糖压片的制备方法,其步骤如下:
1、原料选取:选取新鲜无虫害原料备用;
2、预处理:将各原辅料40℃恒温干燥箱烘干,超微粉碎,过80目筛;
3、苦荞D-手性肌醇提取:采用三维立体超声波提取技术对苦荞D-手性肌醇进行提取,经单因素及正交试验探究出最佳提取条件为:50%乙醇提取,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
4、苦瓜活性成分提取:采用三维立体超声波提取技术对苦瓜活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
5、桑葚活性成分提取:采用三维立体超声波提取技术对桑葚活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
6、马齿苋抑菌剂提取:采用三维立体超声辅助提取技术,以蒸馏水为提取溶剂,料液比为1:30~50,温度为50 ℃,功率400 W,时间为30 min,浓缩至含水量低于15%;
7、南瓜多糖提取:采用超声波协同纤维素酶法提取南瓜多糖,柠檬酸钠缓冲液调节pH在4.0~5.5,温度在45~65℃之间(不同来源的纤维素酶有不同的最佳作用条件)加酶质量分数1.5%,超声功率200 W,超声时间20min,采用Sevage法脱蛋白得南瓜精多糖溶液,经过浓缩、醇沉、真空冻干得到南瓜精多糖,多糖质量分数高达70%。
8、大豆降糖肽提取:
1)碱提酸沉提大豆蛋白:大豆豆粕用石油醚(1:15~20)脱脂,烘干。将脱脂大豆豆粕用去离子水溶解,料液比1:10,用0.2 mol/L Na OH溶液调节p H至8.5~9.0,静置60 min,5000r/min离心15 min,上清液用0.2 mol/L HCl溶液调p H至4.0~4.5,静置30 min,再次离心,沉淀即为大豆蛋白。
2)超声前处理-酶解大豆降糖肽:将大豆蛋白粉按料液比1:20~25加入去离子水,超声时间30min、超声处理温度50℃、超声功率400W。之后调节pH至 9~11,加碱性蛋白酶1.5~2.5% ,酶解温度50~60℃,酶解时间4~6 h,升温至70℃灭酶,调节p H,离心,上清液浓缩,真空冻干得到大豆降糖肽。
9、真空冻干:用真空冻干机在0.4~0.7mbar,温度为-50℃~ -40℃。
10、粉碎:将真空冻干的南瓜多糖、大豆降糖肽、木糖醇超微粉碎。
二、三维混合、制粒:将南瓜多糖10%、大豆降糖肽10%、木糖醇20%、柠檬酸0.3%和β-环状糊精8.7%放入三维混合机搅拌30min~60min,加入苦荞D-手性肌醇浓缩液30%、苦瓜浓缩液5%、桑葚浓缩液5%、马齿苋抑菌剂10%,多次敷粉,粉粹,加入适量乙醇润湿后制粒;
三、压片:经60℃干燥后,加入硬脂酸镁1%混匀,放入压片机中直接压片,制得直径为(0.3cm~1.0cm),厚度为(0.3cm~0.4cm)的复合片剂。
实施例2
一种苦荞D-手性肌醇复合降糖压片的制备方法,其步骤如下:
1、原料选取:选取新鲜无虫害原料备用;
2、预处理:将各原辅料40℃恒温干燥箱烘干,超微粉碎,过80目筛;
3、苦荞D-手性肌醇提取:采用三维立体超声波提取技术对苦荞D-手性肌醇进行提取,经单因素及正交试验探究出最佳提取条件为:50%乙醇提取,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
4、决明子活性成分提取:采用三维立体超声波提取技术对决明子活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
5、西洋参活性成分提取:采用三维立体超声波提取技术对西洋参活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
6、橘皮活性成分提取:采用三维立体超声波提取技术对橘皮活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
7、马齿苋抑菌剂提取:采用三维立体超声辅助提取技术,以蒸馏水为提取溶剂,料液比为1:30~50,温度为50 ℃,功率400 W,时间为30 min,浓缩至含水量低于15%;
8、黑木耳多糖:采用超声波协同复合酶法提取黑木耳多糖,柠檬酸钠缓冲液调节pH在4.0~5.5,木瓜蛋白酶、糖化酶、果胶酶(1:1:1),加酶量700 U/g(原料),料液比1:60、酶解pH5、酶解时间1.5 h、酶解温度50 ℃,超声功率200 W,超声时间20min,采用Sevage法脱蛋白得黑木耳精多糖溶液,经过浓缩、醇沉、真空冻干得到黑木耳精多糖,
9、大豆降糖肽提取:
1)碱提酸沉提大豆蛋白:大豆豆粕用石油醚(1:15~20)脱脂,烘干。将脱脂大豆豆粕用去离子水溶解,料液比1:10,用0.2 mol/L Na OH溶液调节p H至8.5~9.0,静置60 min,5000r/min离心15 min,上清液用0.2 mol/L HCl溶液调p H至4.0~4.5,静置30 min,再次离心,沉淀即为大豆蛋白。
2)超声前处理-酶解大豆降糖肽:将大豆蛋白粉按料液比1:20~25加入去离子水,超声时间30min、超声处理温度50℃、超声功率400W。之后调节pH至 9~11,加碱性蛋白酶1.5~2.5% ,酶解温度50~60℃,酶解时间4~6 h,升温至70℃灭酶,调节p H,离心,上清液浓缩,真空冻干得到大豆降糖肽。
10、真空冻干:用真空冻干机在0.4~0.7mbar,温度为-50℃~ -40℃。
11、粉碎:将真空冻干的黑木耳多糖、大豆降糖肽、木糖醇和麦芽糖醇超微粉碎。
二、三维混合、制粒:将黑木耳多糖13%、大豆降糖肽8%、木糖醇10%、麦芽糖醇10%、柠檬酸0.5%和β-环状糊精3.9%放入三维混合机搅拌30min~60min,加入苦荞D-手性肌醇浓缩液20%、决明子浓缩液7%、西洋参浓缩液7%、橘皮浓缩液7%、马齿苋抑菌剂13%,多次敷粉,粉粹,加入适量乙醇润湿后制粒;
三、压片:经60℃干燥后放入,加入硬脂酸镁0.6%混匀,压片机中直接压片,制得直径为(0.3cm~1.0cm),厚度为(0.3cm~0.4cm)的复合片剂。
实施例3
一种苦荞D-手性肌醇复合降糖压片的制备方法,其步骤如下:
1、原料选取:选取新鲜无虫害原料备用;
2、预处理:将各原辅料40℃恒温干燥箱烘干,超微粉碎,过80目筛;
3、苦荞D-手性肌醇提取:采用三维立体超声波提取技术对苦荞D-手性肌醇进行提取,经单因素及正交试验探究出最佳提取条件为:50%乙醇提取,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
4、西洋参活性成分提取:采用三维立体超声波提取技术对西洋参活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
5、橘皮活性成分提取:采用三维立体超声波提取技术对橘皮活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
6、金银花活性成分提取:采用三维立体超声波提取技术对金银花活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
7、葛根活性成分提取:采用三维立体超声波提取技术对葛根活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
8、黄芪活性成分提取:采用三维立体超声波提取技术对黄芪活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
9、马齿苋抑菌剂提取:采用三维立体超声辅助提取技术,以蒸馏水为提取溶剂,料液比为1:30~50,温度为50 ℃,功率400 W,时间为30 min,浓缩至含水量低于15%;
10、南瓜多糖提取:采用超声波协同纤维素酶法提取南瓜多糖,柠檬酸钠缓冲液调节pH在4.0~5.5,温度在45~65℃之间(不同来源的纤维素酶有不同的最佳作用条件)加酶质量分数1.5%,超声功率200 W,超声时间20min,采用Sevage法脱蛋白得南瓜精多糖溶液,经过浓缩、醇沉、真空冻干得到南瓜精多糖,多糖质量分数高达70%。
11、黑木耳多糖:采用超声波协同复合酶法提取黑木耳多糖,柠檬酸钠缓冲液调节pH在4.0~5.5,木瓜蛋白酶、糖化酶、果胶酶(1:1:1),加酶量700 U/g(原料),料液比1:60、酶解pH 5、酶解时间1.5 h、酶解温度50 ℃,超声功率200 W,超声时间20min,采用Sevage法脱蛋白得黑木耳精多糖溶液,经过浓缩、醇沉、真空冻干得到黑木耳精多糖,
12、大豆降糖肽提取:
1)碱提酸沉提大豆蛋白:大豆豆粕用石油醚(1:15~20)脱脂,烘干。将脱脂大豆豆粕用去离子水溶解,料液比1:10,用0.2 mol/L Na OH溶液调节p H至8.5~9.0,静置60 min,5000r/min离心15 min,上清液用0.2 mol/L HCl溶液调p H至4.0~4.5,静置30 min,再次离心,沉淀即为大豆蛋白。
2)超声前处理-酶解大豆降糖肽:将大豆蛋白粉按料液比1:20~25加入去离子水,超声时间30min、超声处理温度50℃、超声功率400W。之后调节pH至 9~11,加碱性蛋白酶1.5~2.5% ,酶解温度50~60℃,酶解时间4~6 h,升温至70℃灭酶,调节p H,离心,上清液浓缩,真空冻干得到大豆降糖肽。
13、真空冻干:用真空冻干机在0.4~0.7mbar,温度为-50℃~ -40℃。
14、粉碎:将真空冻干的南瓜多糖、黑木耳多糖、大豆降糖肽、木糖醇超微粉碎。
二、三维混合、制粒:将南瓜多糖8%、黑木耳多糖8%、大豆降糖肽16%、木糖醇13%、柠檬酸0.8%和β-环状糊精3.4%放入三维混合机搅拌30min~60min,加入苦荞D-手性肌醇浓缩液15%、西洋参浓缩液4%、橘皮浓缩液4%、金银花浓缩液4%、葛根浓缩液8%、黄芪浓缩液8%、马齿苋抑菌剂7%,多次敷粉,粉粹,加入适量乙醇润湿后制粒;
三、压片:经60℃干燥后,加入硬脂酸镁0.8%混匀,放入压片机中直接压片,制得直径为(0.3cm~1.0cm),厚度为(0.3cm~0.4cm)的复合片剂。
实施例4
一种苦荞D-手性肌醇复合降糖压片的制备方法,其步骤如下:
1、原料选取:选取新鲜无虫害原料备用;
2、预处理:将各原辅料40℃恒温干燥箱烘干,超微粉碎,过80目筛;
3、苦荞D-手性肌醇提取:采用三维立体超声波提取技术对苦荞D-手性肌醇进行提取,经单因素及正交试验探究出最佳提取条件为:50%乙醇提取,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
4、苦瓜活性成分提取:采用三维立体超声波提取技术对苦瓜活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
5、桑葚活性成分提取:采用三维立体超声波提取技术对桑葚活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
6、决明子活性成分提取:采用三维立体超声波提取技术对决明子活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
7、西洋参活性成分提取:采用三维立体超声波提取技术对西洋参活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
8、橘皮活性成分提取:采用三维立体超声波提取技术对橘皮活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
9、金银花活性成分提取:采用三维立体超声波提取技术对金银花活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
10、葛根活性成分提取:采用三维立体超声波提取技术对葛根活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
11、黄芪活性成分提取:采用三维立体超声波提取技术对黄芪活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
12、马齿苋抑菌剂提取:采用三维立体超声辅助提取技术,以蒸馏水为提取溶剂,料液比为1:30~50,温度为50 ℃,功率400 W,时间为30 min,浓缩至含水量低于15%;
13、南瓜多糖提取:采用超声波协同纤维素酶法提取南瓜多糖,柠檬酸钠缓冲液调节pH在4.0~5.5,温度在45~65℃之间(不同来源的纤维素酶有不同的最佳作用条件)加酶质量分数1.5%,超声功率200 W,超声时间20min,采用Sevage法脱蛋白得南瓜精多糖溶液,经过浓缩、醇沉、真空冻干得到南瓜精多糖,多糖质量分数高达70%。
14、黑木耳多糖:采用超声波协同复合酶法提取黑木耳多糖,柠檬酸钠缓冲液调节pH在4.0~5.5,木瓜蛋白酶、糖化酶、果胶酶(1:1:1),加酶量700 U/g(原料),料液比1:60、酶解pH 5、酶解时间1.5 h、酶解温度50 ℃,超声功率200 W,超声时间20min,采用Sevage法脱蛋白得黑木耳精多糖溶液,经过浓缩、醇沉、真空冻干得到黑木耳精多糖,
15、大豆降糖肽提取:
1)碱提酸沉提大豆蛋白:大豆豆粕用石油醚(1:15~20)脱脂,烘干。将脱脂大豆豆粕用去离子水溶解,料液比1:10,用0.2 mol/L Na OH溶液调节p H至8.5~9.0,静置60 min,5000r/min离心15 min,上清液用0.2 mol/L HCl溶液调p H至4.0~4.5,静置30 min,再次离心,沉淀即为大豆蛋白。
2)超声前处理-酶解大豆降糖肽:将大豆蛋白粉按料液比1:20~25加入去离子水,超声时间30min、超声处理温度50℃、超声功率400W。之后调节pH至 9~11,加碱性蛋白酶1.5~2.5% ,酶解温度50~60℃,酶解时间4~6 h,升温至70℃灭酶,调节p H,离心,上清液浓缩,真空冻干得到大豆降糖肽。
16、真空冻干:用真空冻干机在0.4~0.7mbar,温度为-50℃~ -40℃。
17、粉碎:将真空冻干的南瓜多糖、黑木耳多糖、大豆降糖肽、木糖醇超微粉碎。
二、三维混合、制粒:将南瓜多糖6%、、黑木耳多糖6%、大豆降糖肽12%、木糖醇10%、柠檬酸0.6%和β-环状糊精4.7%放入三维混合机搅拌30min~60min,加入苦荞D-手性肌醇浓缩液18%、苦瓜浓缩液3%、桑葚浓缩液3%、决明子浓缩液3%、西洋参浓缩液3%、橘皮浓缩液3%、金银花浓缩液3%、葛根浓缩液5%、黄芪浓缩液5%、马齿苋抑菌剂14%,多次敷粉,粉粹,加入适量乙醇润湿后制粒;
三、压片:经60℃干燥后,加入硬脂酸镁0.7%混匀,放入压片机中直接压片,制得直径为(0.3cm~1.0cm),厚度为(0.3cm~0.4cm)的复合片剂。
实施例5
一种苦荞D-手性肌醇复合降糖压片的制备方法,其步骤如下:
1、原料选取:选取新鲜无虫害原料备用;
2、预处理:将各原辅料40℃恒温干燥箱烘干,超微粉碎,过80目筛;
3、苦荞D-手性肌醇提取:采用三维立体超声波提取技术对苦荞D-手性肌醇进行提取,经单因素及正交试验探究出最佳提取条件为:50%乙醇提取,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
4、苦瓜活性成分提取:采用三维立体超声波提取技术对苦瓜活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
5、桑葚活性成分提取:采用三维立体超声波提取技术对桑葚活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
6、决明子活性成分提取:采用三维立体超声波提取技术对决明子活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
7、西洋参活性成分提取:采用三维立体超声波提取技术对西洋参活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
8、橘皮活性成分提取:采用三维立体超声波提取技术对橘皮活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
9、金银花活性成分提取:采用三维立体超声波提取技术对金银花活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
10、葛根活性成分提取:采用三维立体超声波提取技术对葛根活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
11、黄芪活性成分提取:采用三维立体超声波提取技术对黄芪活性成分进行提取,提取溶剂为50%乙醇,料液比1:10~30,超声温度50℃,超声时间30min,功率400W,浓缩至含水量低于15%;
12、马齿苋抑菌剂提取:采用三维立体超声辅助提取技术,以蒸馏水为提取溶剂,料液比为1:30~50,温度为50 ℃,功率400 W,时间为30 min,浓缩至含水量低于15%;
13、南瓜多糖提取:采用超声波协同纤维素酶法提取南瓜多糖,柠檬酸钠缓冲液调节pH在4.0~5.5,温度在45~65℃之间(不同来源的纤维素酶有不同的最佳作用条件)加酶质量分数1.5%,超声功率200 W,超声时间20min,采用Sevage法脱蛋白得南瓜精多糖溶液,经过浓缩、醇沉、真空冻干得到南瓜精多糖,多糖质量分数高达70%。
14、黑木耳多糖:采用超声波协同复合酶法提取黑木耳多糖,柠檬酸钠缓冲液调节pH在4.0~5.5,木瓜蛋白酶、糖化酶、果胶酶(1:1:1),加酶量700 U/g(原料),料液比1:60、酶解pH 5、酶解时间1.5 h、酶解温度50 ℃,超声功率200 W,超声时间20min,采用Sevage法脱蛋白得黑木耳精多糖溶液,经过浓缩、醇沉、真空冻干得到黑木耳精多糖,
15、大豆降糖肽提取:
1)碱提酸沉提大豆蛋白:大豆豆粕用石油醚(1:15~20)脱脂,烘干。将脱脂大豆豆粕用去离子水溶解,料液比1:10,用0.2 mol/L Na OH溶液调节p H至8.5~9.0,静置60 min,5000r/min离心15 min,上清液用0.2 mol/L HCl溶液调p H至4.0~4.5,静置30 min,再次离心,沉淀即为大豆蛋白。
2)超声前处理-酶解大豆降糖肽:将大豆蛋白粉按料液比1:20~25加入去离子水,超声时间30min、超声处理温度50℃、超声功率400W。之后调节pH至 9~11,加碱性蛋白酶1.5~2.5% ,酶解温度50~60℃,酶解时间4~6 h,升温至70℃灭酶,调节p H,离心,上清液浓缩,真空冻干得到大豆降糖肽。
16、真空冻干:用真空冻干机在0.4~0.7mbar,温度为-50℃~ -40℃。
17、粉碎:将真空冻干的南瓜多糖、黑木耳多糖、大豆降糖肽、木糖醇和麦芽糖醇超微粉碎。
二、三维混合、制粒:将南瓜多糖10%、黑木耳多糖10%、大豆降糖肽7%、木糖醇3%、麦芽糖醇3%、柠檬酸0.4%和β-环状糊精4.1%放入三维混合机搅拌30min~60min,加入苦荞D-手性肌醇浓缩液16%、苦瓜浓缩液5%、桑葚浓缩液5%、决明子浓缩液5%、西洋参浓缩液5%、橘皮浓缩液5%、金银花浓缩液5%、葛根浓缩液4%、黄芪浓缩液4%、马齿苋抑菌剂8%,多次敷粉,粉粹,加入适量乙醇润湿后制粒;
三、压片:经60℃干燥后,加入硬脂酸镁0.5%混匀,放入压片机中直接压片,制得直径为(0.3cm~1.0cm),厚度为(0.3cm~0.4cm)的复合片剂。
Claims (8)
1.一种苦荞D-手性肌醇复合降糖压片,其特征在于所述复合片剂按照以下质量百分比的原辅料制备而成:苦荞D-手性肌醇浓缩液15~30%、苦瓜浓缩液3~5%、桑葚浓缩液3~5%、决明子浓缩液3~7%、西洋参浓缩液3~7%、橘皮浓缩液3~7%、金银花浓缩液3~5%、葛根浓缩液4~8%、黄芪浓缩液4~8%、马齿苋抑菌剂7~14%、南瓜多糖6~10%、黑木耳多糖6~13%、大豆降糖肽7~16%、木糖醇3~20%、麦芽糖醇3~10%、柠檬酸0.3~0.8%、β-环状糊精3.4~8.7%、硬脂酸镁0.5~1%。
2.根据权利要求1所述的一种苦荞D-手性肌醇复合降糖压片,其特征在于所述复合片剂由以下原辅料制备而成:苦荞D-手性肌醇浓缩液30%、苦瓜浓缩液5%、桑葚浓缩液5%、马齿苋抑菌剂10%、南瓜多糖10%、大豆降糖肽10%、木糖醇20%、柠檬酸0.3%、β-环状糊精8.7%、硬脂酸镁1%。
3.根据权利要求1所述的一种苦荞D-手性肌醇复合降糖压片,其特征在于所述复合片剂由以下原辅料制备而成:苦荞D-手性肌醇浓缩液20%、决明子浓缩液7%、西洋参浓缩液7%、橘皮浓缩液7%、马齿苋抑菌剂13%、黑木耳多糖13%、大豆降糖肽8%、木糖醇10%、麦芽糖醇10%、柠檬酸0.5%、β-环状糊精3.9%、硬脂酸镁0.6%。
4.根据权利要求1所述的一种苦荞D-手性肌醇复合降糖压片,其特征在于所述复合片剂由以下原辅料制备而成:苦荞D-手性肌醇浓缩液15%、西洋参浓缩液4%、橘皮浓缩液4%、金银花浓缩液4%、葛根浓缩液8%、黄芪浓缩液8%、马齿苋抑菌剂7%、南瓜多糖8%、黑木耳多糖8%、大豆降糖肽16%、木糖醇13%、柠檬酸0.8%、β-环状糊精3.4%、硬脂酸镁0.8%。
5.根据权利要求1所述的一种苦荞D-手性肌醇复合降糖压片,其特征在于所述复合片剂由以下原辅料制备而成:苦荞D-手性肌醇浓缩液18%、苦瓜浓缩液3%、桑葚浓缩液3%、决明子浓缩液3%、西洋参浓缩液3%、橘皮浓缩液3%、金银花浓缩液3%、葛根浓缩液5%、黄芪浓缩液5%、马齿苋抑菌剂14%、南瓜多糖6%、、黑木耳多糖6%、大豆降糖肽12%、木糖醇10%、柠檬酸0.6%、β-环状糊精4.7%、硬脂酸镁0.7%。
6.根据权利要求1所述的一种苦荞D-手性肌醇复合降糖压片,其特征在于所述复合片剂由以下原辅料制备而成:苦荞D-手性肌醇浓缩液16%、苦瓜浓缩液5%、桑葚浓缩液5%、决明子浓缩液5%、西洋参浓缩液5%、橘皮浓缩液5%、金银花浓缩液5%、葛根浓缩液4%、黄芪浓缩液4%、马齿苋抑菌剂8%、南瓜多糖10%、黑木耳多糖10%、大豆降糖肽7%、木糖醇3%、麦芽糖醇3%、柠檬酸0.4%、β-环状糊精4.1%、硬脂酸镁0.5%。
7.根据权利要求1所述的一种苦荞D-手性肌醇复合降糖压片,其特征在于所述复合片剂以马齿苋活性成分作为抑菌剂、不添加其他防腐剂,安全健康,物不良作用。
8.根据权利要求1所述的一种苦荞D-手性肌醇复合降糖压片,其特征在于所述复合片剂采用超声波协同酶法提取南瓜多糖和黑木耳多糖,并用Sevage法脱蛋白获得精多糖,其中的酶解温度和pH值受酶来源的影响,可以作适度调整。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910761225.1A CN110326788A (zh) | 2019-08-17 | 2019-08-17 | 一种苦荞d-手性肌醇复合降糖压片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910761225.1A CN110326788A (zh) | 2019-08-17 | 2019-08-17 | 一种苦荞d-手性肌醇复合降糖压片及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110326788A true CN110326788A (zh) | 2019-10-15 |
Family
ID=68149758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910761225.1A Pending CN110326788A (zh) | 2019-08-17 | 2019-08-17 | 一种苦荞d-手性肌醇复合降糖压片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110326788A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113577239A (zh) * | 2021-07-30 | 2021-11-02 | 山东第一医科大学(山东省医学科学院) | 一种西洋参糖肽及其制备方法与应用 |
CN116508849A (zh) * | 2023-02-20 | 2023-08-01 | 西北农林科技大学 | 一种配方羊乳粉、制备方法及其应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101062114A (zh) * | 2007-05-28 | 2007-10-31 | 山西省农业科学院农产品综合利用研究所 | 一种从苦荞麸皮中提取黄酮的方法 |
CN101856126A (zh) * | 2010-06-22 | 2010-10-13 | 西昌航飞苦荞科技发展有限公司 | 苦荞食品基料、由该基料制成的食品或保健食品及其制法 |
CN102948749A (zh) * | 2012-11-23 | 2013-03-06 | 乔德京 | 洋参苦葛平唐胶囊 |
CN107581587A (zh) * | 2017-07-21 | 2018-01-16 | 哈尔滨工业大学 | 一种中老年人专用的降血糖黑木耳片剂制备配方 |
CN108949887A (zh) * | 2018-09-04 | 2018-12-07 | 哈尔滨工业大学 | 一种大豆多功能降糖肽的制备方法 |
CN109123306A (zh) * | 2018-09-05 | 2019-01-04 | 哈尔滨工业大学 | 一种苦荞复合降糖固体饮料的制作方法 |
CN109198348A (zh) * | 2017-06-30 | 2019-01-15 | 浙江京新生物科技有限公司 | 一种降糖肽固体饮料及其应用 |
-
2019
- 2019-08-17 CN CN201910761225.1A patent/CN110326788A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101062114A (zh) * | 2007-05-28 | 2007-10-31 | 山西省农业科学院农产品综合利用研究所 | 一种从苦荞麸皮中提取黄酮的方法 |
CN101856126A (zh) * | 2010-06-22 | 2010-10-13 | 西昌航飞苦荞科技发展有限公司 | 苦荞食品基料、由该基料制成的食品或保健食品及其制法 |
CN102948749A (zh) * | 2012-11-23 | 2013-03-06 | 乔德京 | 洋参苦葛平唐胶囊 |
CN109198348A (zh) * | 2017-06-30 | 2019-01-15 | 浙江京新生物科技有限公司 | 一种降糖肽固体饮料及其应用 |
CN107581587A (zh) * | 2017-07-21 | 2018-01-16 | 哈尔滨工业大学 | 一种中老年人专用的降血糖黑木耳片剂制备配方 |
CN108949887A (zh) * | 2018-09-04 | 2018-12-07 | 哈尔滨工业大学 | 一种大豆多功能降糖肽的制备方法 |
CN109123306A (zh) * | 2018-09-05 | 2019-01-04 | 哈尔滨工业大学 | 一种苦荞复合降糖固体饮料的制作方法 |
Non-Patent Citations (2)
Title |
---|
史磊,等: "高效液相色谱-蒸发光散射检测法测定苦瓜降糖丸中黄芪甲苷的含量", 《中国中医药信息杂志》 * |
邱军强,等: "超声波处理对多糖理化性质和生物活性的影响", 《食品研究与开发》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113577239A (zh) * | 2021-07-30 | 2021-11-02 | 山东第一医科大学(山东省医学科学院) | 一种西洋参糖肽及其制备方法与应用 |
CN116508849A (zh) * | 2023-02-20 | 2023-08-01 | 西北农林科技大学 | 一种配方羊乳粉、制备方法及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101264177B (zh) | 一种具有提神清咽利喉作用的压片糖果 | |
CN103103099B (zh) | 一种复方霍斛蓉芝保健酒及生产工艺 | |
CN104799146A (zh) | 一种改善亚健康的功能性营养食品组合及其制备方法 | |
CN103750107B (zh) | 一种具有降糖功能的保健品 | |
CN103285231A (zh) | 一种用于糖尿病辅助治疗的药物组合物及其制法 | |
CN103734751A (zh) | 一种复合膳食纤维及其制法 | |
CN105942498A (zh) | 具有治疗糖尿病作用的功能性营养食品组合及其制备方法 | |
CN103168883A (zh) | 可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂及其制备方法 | |
CN105707637A (zh) | 一种降糖固体饮料及其制备方法 | |
CN101243882B (zh) | 具有降血脂功能的保健食品及其制备方法 | |
KR20190045057A (ko) | 비만 개선용 다이어트 한방 식품 조성물 및 그 제조방법 | |
CN103830496A (zh) | 一种辅助降糖的组合物 | |
CN110326788A (zh) | 一种苦荞d-手性肌醇复合降糖压片及其制备方法 | |
CN1329049C (zh) | 降血糖、降血压的药物 | |
CN103251698A (zh) | 一种具有解酒保肝护胃功效的葛根饮液及其制法 | |
CN105795292A (zh) | 一种玉参饮品及其制备方法 | |
CN108813501A (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
KR100522579B1 (ko) | 항스트레스 효과를 갖는 황금 및 오미자 혼합 추출물을함유하는 약학조성물 | |
CN100462085C (zh) | 一种调节血糖、血压和血脂的药品或保健食品片剂及其制备方法 | |
CN101496604A (zh) | 一种具有降血脂功能的营养食品及其制备方法 | |
CN101336965A (zh) | 一种用于改善糖耐量、降低血糖的中成药及其制备方法 | |
CN101564511B (zh) | 一种治疗糖尿病的天然蛋白制品及制作方法 | |
CN105327115B (zh) | 一种防治ⅱ型糖尿病桑黄通泻配方及制备工艺 | |
KR20150031373A (ko) | 비타민나무 잎 추출물을 유효성분으로 함유하는 비만 예방 또는 치료용 약학 조성물 및 식품 조성물 | |
CN1943448A (zh) | 竹汁银杏饮料及其生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191015 |
|
RJ01 | Rejection of invention patent application after publication |